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Abstract
Covariate-adaptive randomization schemes such as the minimization and stratified permuted
blocks are often applied in clinical trials to balance treatment assignments across prognostic fac-
tors. The existing theoretical developments on inference after covariate-adaptive randomization
are mostly limited to situations where a correct model between the response and covariates can
be specified or the randomization method has well-understood properties. Based on stratification
with covariate levels utilized in randomization and a further adjusting for covariates not used in
randomization, in this article we propose several estimators for model free inference on average treat-
ment effect defined as the difference between response means under two treatments. We establish
asymptotic normality of the proposed estimators under all popular covariate-adaptive randomiza-
tion schemes including the minimization whose theoretical property is unclear, and we show that
the asymptotic distributions are invariant with respect to covariate-adaptive randomization meth-
ods. Consistent variance estimators are constructed for asymptotic inference. Asymptotic relative
efficiencies and finite sample properties of estimators are also studied. We recommend using one of
our proposed estimators for valid and model free inference after covariate-adaptive randomization.
Keywords: Adjusting for covariates; Balancedness of treatment assignments; Efficiency; Gen-
eralized regression; Model free inference; Multiple treatment arms; Stratification; Variance estima-
tion.
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1 Introduction
Consider a clinical trial to compare k treatments with given treatment assignment proportions
pi1, . . . , pik, where k ≥ 2 is a fixed positive integer,
∑k
t=1 pit = 1, and pit can be any known number
strictly between 0 and 1. In many trials patients are not all available for simultaneous assignment
of treatments but rather arrive sequentially and must be treated immediately. Thus, simple ran-
domization, which assigns patients to treatments completely at random, may yield sample sizes
not following the assignment proportions across prognostic factors or covariates, e.g., institution,
disease stage, prior treatment, gender, and age, which are thought to have significant influence
on the responses of interest. A remedy is to apply covariate-adaptive randomization, i.e., treat-
ment assignment of the ith patient depends on the observed covariate value of this patient and
the assignments and covariate values of all i − 1 previously assigned patients. In this article, we
focus on enforcing assignment allocation across levels of a covariate vector Z whose components
are discrete or discretized continuous covariates. There are model-based approaches of balancing
discrete or continuous covariates for estimation efficiency (Atkinson 1982, 1999, 2002; Rosenberger
and Sverdlov 2008; Senn et al. 2010; Baldi Antognini and Zagoraiou 2011), which are not further
considered in this article. The oldest method of balancing covariates is the minimization (Taves
1974) intended to balance treatment assignments across marginal levels of Z: it assigns the ith
patient by minimizing a weighted sum of squared or absolute differences between the numbers of
patients, up to the ith, assigned to treatments over marginal levels of Z. Pocock and Simon (1975)
extended Taves’ procedure to achieving minimization with a given probability, which is still re-
ferred to as the minimization method. Other popular covariate-adaptive randomization methods
include the stratified permuted block randomization (Zelen 1974), the stratified biased coin (Shao
et al. 2010; Kuznetsova and Johnson 2017), and the stratified urn design (Wei 1977; Zhao and
Ramakrishnan 2016). See Schulz and Grimes (2002) and Rosenberger and Sverdlov (2008) for nice
summaries. As pointed out in Taves (2010), from 1989 to 2008, over 500 clinical trials implemented
the minimization method to balance important covariates, despite some criticisms by Smith (1984)
and Senn et al. (2010). According to a recent review of nearly 300 clinical trials published in 2009
and 2014 (Ciolino et al. 2019), 237 of them used covariate-adaptive randomization.
Although data are collected under covariate-adaptive randomization, conventional inference
procedures constructed based on simple randomization are often applied in practice. This has raised
concerns because statistical inference on treatment effects should be made using procedures valid
under the particular randomization scheme used in data collection. Applying conventional inference
after covariate-adaptive randomization may lead to invalid results, especially for the minimization
because its theoretical property remains largely unclear. In its 2015 guideline, European Medicines
Agency (2015) raised concerns and specifically pointed out that “possible implications of dynamic
allocation methods [minimization] on the analysis e.g. with regard to bias and Type I error control
should be carefully considered, . . . conventional statistical methods do not always control the Type
I error”.
Starting with Shao et al. (2010), there has been significant progress in understanding the the-
oretical properties of statistical tests under covariate-adaptive randomization, e.g., Hu and Hu
(2012), Shao and Yu (2013), Ma et al. (2015), Bugni et al. (2018, 2019), Ye (2018), and Ye and
Shao (2020). Another important stream of statistical inference methods is based on permutation
tests or re-randomization inference, e.g., Simon and Simon (2011), Kaiser (2012), and Bugni et al.
(2018). However, except for Bugni et al. (2019), all theoretical results are established under the
assumption that either a correct model between the responses of interest and covariates is available
or the covariate-adaptive randomization procedure has a well-understood property, described as
type 1 or type 2 later in §2 of the current paper. It should be noted that model misspecification
often occurs, especially when there are many covariates, and the minimization method is neither
type 1 nor type 2. The minimization is applied in practice very often (Pocock and Simon 1975),
mainly because it aims to minimize the imbalance across marginal levels of Z, not every joint level
of Z, which is sufficient in many applications. Enforcing treatment balance in every joint level of
Z may cause sparsity of data when the dimension of Z is not small.
To fill the gap, in this paper we propose asymptotically valid inference on the average treatment
effect defined as the difference between population response means of every treatment pair, under
covariate-adaptive randomization including minimization. Our main idea is to apply stratification
according to the levels of discrete Z and to adjust for covariates not used in treatment random-
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ization through generalized regression for improving efficiency. Our estimator without adjusting
for covariates, which is not the most efficient one, coincides with the estimator derived under a
different approach in the recent publication (Bugni et al. 2019). Asymptotic normality of the pro-
posed treatment effect estimators is established with explicit limiting variance formulas that can
be used for inference as well as comparing relative efficiencies. Our results are not only model-free,
i.e., only the existence of second-order moments of the responses and covariates are required, but
also invariant with respect to covariate-adaptive randomization schemes, i.e., the same inference
procedure can be applied under any covariate-adaptive randomization. We also study and com-
pare inference procedures by simulations and illustrate our method in a real data example. R
codes for the methods proposed in this paper can be found in the R package RobinCar posed at
https://github.com/tye27/RobinCar.
2 Preliminaries
Let I be the treatment indicator vector, which equals et if the patient is assigned to treatment t,
t = 1, . . . , k, where et denotes a vector with only the tth component being 1 while the rest being
0. Let Y (t) be the potential response under treatment t, W be a vector of all observed covariates,
and Z be a discrete function of W utilized in covariate-adaptive randomization. For patient i, let
Ii, Wi, and Y
(t)
i , t = 1, . . . , k, be realizations of I, W , and Y
(t), t = 1, . . . , k, respectively, where
i = 1, . . . , n, and n is the total number of patients in all treatment arms. For every patient i, Ii is
generated after Zi is observed, and only the potential response from the treatment indicated by Ii
is observed, i.e., we observe Yi = Y
(t)
i if and only if Ii = et.
After all treatment assignments are made and responses are collected, we would like to make
inference based on the observed data {Wi, Ii, Yi, i = 1, . . . , n}. In this paper, we consider inference
on the average treatment effect between treatments t and s,
θ = E(Y (t) − Y (s)), (1)
where E denotes the population expectation and s 6= t are given integers between 1 and k. Note
that θ in (1) depends on t and s, but a subscript is omitted for simplicity, as we mainly consider
the average treatment effect for two fixed treatment arms.
For our inference procedure studied in §3, we describe some minimal conditions. The first one
is about the population for potential responses and covariates.
(C1) (Y
(1)
i , . . . , Y
(k)
i ,Wi), i = 1, . . . , n, are independent and identically distributed as
(Y (1), . . . , Y (k),W ) and Y (t) has finite second-order moments, t = 1, . . . , k.
This condition is model-free: there is no assumption on the relationship between W and the po-
tential response Y (t) that may be continuous or discrete.
Under simple randomization, Ii’s are independent of (Y
(1)
i , . . . , Y
(k)
i ,Wi)’s and are independent
and identically distributed with pr(Ii = et) = pit. To enforce assignment proportions at each joint
level of Z treated as stratum, three popular covariate-adaptive randomization schemes are the
stratified permuted block randomization method (Zelen 1974), the stratified biased coin method
(Shao et al. 2010; Kuznetsova and Johnson 2017), and the stratified urn design (Wei 1977; Zhao
and Ramakrishnan 2016).
The minimization (Taves 1974; Pocock and Simon 1975; Han et al. 2009) is the same as the
stratified biased coin method if Z is one-dimensional, but is very different from the above three
stratification methods with a multivariate Z. It aims to enforce assignment ratio across marginal
levels of Z, not every stratum defined by the joint level of Z. Assignments are made by minimizing
a weighted sum of squared or absolute differences between the numbers of patients assigned to
treatment arms across marginal levels of Z. Because only marginal levels of Z are considered in
minimization, this method is also called the marginal method in Ma et al. (2015) and Ye and Shao
(2020).
We assume the following minimal conditions for covariate-adaptive randomization.
(C2) (Ii, i = 1, . . . , n) and (Y
(1)
i , . . . , Y
(k)
i ,Wi, i = 1, . . . , n) are conditionally independent given
Z1, . . . , Zn.
(C3) Z is discrete with finitely many levels given in a set Z. For each t = 1, . . . , k, pr(Ii = et |
Z1, . . . , Zn) = pit for i = 1, . . . , n, and {n(z)}−1Dt(z) converges to 0 in probability as n→∞
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for every z ∈ Z, where n(z) is the number of patients with Zi = z, and Dt(z) = nt(z)−pitn(z)
with nt(z) being the number of patients with Zi = z assigned to treatment t.
Condition (C2) is reasonable because (i) given Zi’s, Wi’s contain covariates not used in random-
ization, and (ii) treatment assignments do not affect the potential responses, although they do
affect the observed responses Yi’s. Condition (C3) holds for most covariate-adaptive randomization
schemes (Baldi Antognini and Zagoraiou 2015), certainly for all schemes considered in this paper,
the minimization and three stratified designs, the permuted block, biased coin, and urn design.
We classify all covariate-adaptive randomization methods into the following three types in terms
of Dt(z) defined in (C3).
Type 1. For every t and z, {n(z)}−1/2Dt(z)→ 0 in probability as n→∞.
Type 2. For every t, Dt(z), z ∈ Z, are independent and, for every t and z, {n(z)}−1/2Dt(z) d−→
N(0, vt) with a known vt > 0, where
d−→ denotes convergence in distribution as n→∞.
Type 3. Methods not in type 1 or 2.
The three types are defined based on their degree in enforcing the balancedness according to
the given assignment proportions within every joint level of Z. Type 1 is the strongest, since Dt(z)
measures the imbalance of assignments within stratum z. The property {n(z)}−1/2Dt(z) → 0 in
probability is stronger than {n(z)}−1Dt(z)→ 0 in probability in (C3). Type 2 is weaker than type
1 in enforcing the balancedness, as it requires {n(z)}−1/2Dt(z) converging in distribution, not in
probability to 0, although it is still stronger than {n(z)}−1Dt(z)→ 0 in probability.
Representatives of type 1 methods are stratified permuted block randomization and stratified
biased coin methods. Specifically, under stratified permuted block randomization, Dt(z) is bounded
by the maximum block size. For the stratified biased coin method, it follows from a result in Efron
(1971) that Dt(z) is bounded in probability. The stratified urn design is type 2 with vt = 1/12
when k = 2 and pi1 = pi2 = 1/2 (Wei 1978). Simple randomization treated as a special case of
covariate-adaptive randomization is also type 2. Finally, the minimization is type 3, since it is
neither type 1 nor type 2 (Ye and Shao 2020). Specifically, under minimization, Dt(z) and Dt(z
′)
with z 6= z′ are not independent, and their relationship is complicated, because assignments are
made according to marginal levels of Z.
For type 1 methods, some theoretical results in statistical testing have been established; see, for
example, Shao et al. (2010), Shao and Yu (2013), Ye (2018), Bugni et al. (2018, 2019), and Ye and
Shao (2020). Bugni et al. (2018, 2019) and Ye and Shao (2020) also considered type 2 methods.
In the next section, we propose inference procedures and establish their asymptotic validity under
general covariate-adaptive randomization including minimization.
3 Inference on Average Treatment Effect
To make asymptotically valid inference on θ defined in (1), the key is to construct an estimator
of θ and derive its asymptotic distribution. Under simple randomization, the simplest estimator is
the response mean difference Y¯t − Y¯s, where Y¯t is the sample mean of responses under treatment
t. Although Y¯t − Y¯s is asymptotically normal under type 1 or 2 covariate-adaptive randomization,
it is generally not efficient as covariate information is not utilized in estimation. More seriously,
the asymptotic distribution of Y¯t− Y¯s is not known under type 3 covariate-adaptive randomization
such as the minimization. Bugni et al. (2018) derived a different estimator of θ, called the strata
fixed effect estimator in their §4.2, but its asymptotic normality is established only for type 1 or 2
covariate-adaptive randomization and, thus, it cannot be used under type 3 randomization such as
the minimization.
Let Y¯t(z) be the sample mean of Yi’s with Zi = z under treatment t. The following stratified
response mean differences with strata being all joint levels of Z is proposed in expression (8) of
Bugni et al. (2019),
θ̂ =
∑
z∈Z
n(z)
n
{Y¯t(z)− Y¯s(z)}, (2)
although Bugni et al. (2019) provided θ̂ in a different form derived under a fully saturated linear
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regression. If the weight n(z)/n in (2) is replaced by the population weight pr(Z = z), then θ̂ is
exactly the stratified estimator in survey sampling. We use n(z)/n in (2) as pr(Z = z) is unknown.
Although θ̂ in (2) utilizes information from Z by stratification and is asymptotically more
efficient than the simple Y¯t − Y¯s or the strata fixed effect estimator in Bugni et al. (2018), it does
not make use of covariate information in W but not in Z. Note that W may contain components
that are not in Z but are related with the potential responses Y (t), t = 1, . . . , k, or some components
of Z are discretized components of W and the remaining information after discretization is still
predictive of Y (t), t = 1, . . . , k.
Let X be a function of W that we want to further adjust for. We now consider improving θ̂
in (2) by utilizing X. To maintain model free estimation, we do not impose any model between
Y (t) and X, but adjust for covariate X within each Z = z by applying the generalized regression
approach in survey sampling, first discussed in Cassel et al. (1976) and studied extensively in the
literature, for example, Sa¨rndal et al. (2003), Lin (2013), Shao and Wang (2014), and Ta et al.
(2020). Since this approach is model-assisted but not model-based, i.e., a model is used to derive
efficient estimators that are still asymptotically valid even if the model is incorrect, it suits our
purpose of utilizing covariates without modeling.
Let Xi be the value of covariate X for patient i, X¯t(z) be the sample mean of Xi’s with Zi = z
under treatment t, and
β̂t(z) =
 ∑
i:Ii=et,Zi=z
{Xi − X¯t(z)}{Xi − X¯t(z)}T
−1 ∑
i:Ii=et,Zi=z
{Xi − X¯t(z)}Yi,
where aT is the transpose of vector a. Within treatment t and Z = z, β̂t(z) is the least squares
estimator of the coefficient vector in front of X under a linear model between Y (t) and X, but the
model is not required to be correct. Then, our first proposed estimator of θ after adjusting for
covariates is
θ̂A =
∑
z∈Z
n(z)
n
{Y¯t,A(z)− Y¯s,A(z)}, Y¯t,A(z) = Y¯t(z)− {X¯t(z)− X¯(z)}T β̂t(z), (3)
where X¯(z) is the sample mean of Xi’s of all patients with Zi = z.
Within Zi = z, if we assume that the linear models under all treatments have the same coefficient
vector for X, such as a homogeneous ANCOVA model with covariate vector X, then we can replace
β̂t(z) by
β̂(z) =
 k∑
t=1
∑
i:Ii=et,Zi=z
{Xi − X¯t(z)}{Xi − X¯t(z)}T
−1 k∑
t=1
∑
i:Ii=et,Zi=z
{Xi − X¯t(z)}Yi.
Again, the model is not required to be correct in order to use β̂(z). This leads to an alternative
estimator of θ after adjusting for covariates,
θ̂B =
∑
z∈Z
n(z)
n
{Y¯t,B(z)− Y¯s,B(z)}, Y¯t,B(z) = Y¯t(z)− {X¯t(z)− X¯(z)}T β̂(z). (4)
When k > 2, both X¯(z) and β̂(z) involve data from patients in treatment arms other than t
and s.
The following theorem proved in the Supplementary Material derives the asymptotic distri-
butions of θ̂ in (2), θ̂A in (3), and θ̂B in (4), under covariate-adaptive randomization including
minimization.
Theorem 1. Assume (C1)-(C3), the existence of second-order moments of X, XY (t), t = 1, . . . , k,
and that var(X | Z = z) is positive definite for every z ∈ Z. As n→∞,
√
n(θ̂ − θ) d−→ N(0, σ2U + σ2V ),
√
n(θ̂A − θ) d−→ N(0, σ2A + σ2V ),
√
n(θ̂B − θ) d−→ N(0, σ2B + σ2V ),
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where
σ2U =E{var(Y (t) | Z)/pit + var(Y (s) | Z)/pis},
σ2A =E[var{Y (t) −XTβt(Z) | Z}/pit + var{Y (s) −XTβs(Z) | Z}/pis]
+ E[{βt(Z)− βs(Z)}Tvar(X | Z){βt(Z)− βs(Z)}],
σ2B =E[var{Y (t) −XTβ(Z) | Z}/pit + var{Y (s) −XTβ(Z) | Z}/pis],
σ2V = var{E(Y (t) − Y (s) | Z)},
t, s = 1, . . . , k, βt(z) = {var(X | Z = z)}−1cov(X,Y (t) | Z = z), and β(z) =
∑k
t=1 pitβt(z).
Theorem 1 is model free and is applicable to any covariate-adaptive randomization method
satisfying (C2)-(C3), most noticeably the minimization for which very little is known about its
theoretical property, as the minimization is neither type 1 nor type 2 described in §2. This provides
a solid foundation for valid and model free inference after minimization.
The asymptotic result in Theorem 1 is invariant with respect to randomization methods, i.e.,
σ2U , σ
2
A, σ
2
B , and σ
2
V do not depend on the randomization scheme. In other words, each estimator of
θ in (2)-(4) has the same asymptotic distribution and efficiency regardless of which randomization
scheme is used for treatment assignments, including simple randomization. This is intrinsically
different from many existing results that are dependent on randomization methods (Shao and Yu
2013; Ma et al. 2015; Bugni et al. 2018). The only result invariant with respect to randomization
methods can be found in the literature is in Bugni et al. (2019) for θ̂ in (2), although it does not
explicitly state this invariance property.
Due to the use of covariate-adaptive randomization, the sample mean Y¯t is not an average
of independent random variables and, thus, the asymptotic distributions of estimators in (2)-(4)
cannot be obtained by directly applying the central limit theorem for sum of independent random
variables. We overcome this difficulty by decomposing θ̂ − θ as the sum of the following two
uncorrelated terms,
U =
∑
z∈Z
n(z)
n
[
{Y¯t(z)− Y¯s(z)} − {E(Y (t) | Z = z)− E(Y (s) | Z = z)}
]
,
V =
∑
z∈Z
n(z)
n
{E(Y (t) | Z = z)− E(Y (s) | Z = z)} − θ.
Conditioned on (I1, . . . , In, Z1, . . . , Zn), U is an average of independent terms so its limiting dis-
tribution can be derived by applying the central limit theorem, which consequently provides the
unconditional asymptotic distribution of U . For V , the only random part is n(z) whose limiting
distribution can be easily derived. For θ̂A or θ̂B , a similar decomposition can be obtained with the
same V and a different U incorporating the covariate adjustment term. Details can be found in the
Supplementary Material.
This decomposition is not only the key to establishing the asymptotic result, but also identifies
two sources of variation. The variation of potential responses Y (t) and Y (s) explained by Z is
represented by σ2U . The variation from treatment effect heterogeneity is measured by σ
2
V . Note
that we allow arbitrary treatment effect heterogeneity, i.e., different subgroups according to levels
of Z may benefit differently from the treatment. If there is no treatment effect heterogeneity, then
σ2V = 0.
The asymptotic relative efficiencies among θ̂, θ̂A and θ̂B are summarized in the following result.
Theorem 2. Under the same assumptions in Theorem 1, for σ2U , σ
2
A, σ
2
B, βt(z) and β(z) defined
in Theorem 1, we have
σ2U − σ2A =E
[{pisβt(Z) + pitβs(Z)}Tvar(X | Z){pisβt(Z) + pitβs(Z)}] {pitpis(pit + pis)}−1
+ E
[
{βt(Z)− βs(Z)}T var(X | Z) {βt(Z)− βs(Z)}
]
{(pit + pis)−1 − 1},
σ2B − σ2A =E
[{βt(Z)− β(Z)}Tvar(X | Z){βt(Z)− β(Z)}]pi−1t
+ E
[{βs(Z)− β(Z)}Tvar(X | Z){βs(Z)− β(Z)}]pi−1s
− E
[
{βt(Z)− βs(Z)}T var(X | Z) {βt(Z)− βs(Z)}
]
.
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Consequently, σ2A ≤ σ2U , where the equality holds if and only if for every z ∈ Z,
pisβt(z) + pitβs(z) = 0 and {βt(z)− βs(z)}(1− pit − pis) = 0; (5)
and σ2A ≤ σ2B, where the equality holds if and only if for every z ∈ Z,
β(z) = {pisβt(z) + pitβs(z)}/(pis + pit) and {βt(z)− βs(z)}(1− pit − pis) = 0. (6)
Theorem 2 indicates that θ̂A is always asymptotically more efficient than θ̂ unless (5) holds,
in which case θ̂ and θ̂A have the same asymptotic efficiency. This theoretically corroborates the
perception that covariate adjustment with a full set of treatment-covariate interactions can not hurt
efficiency. When there are more than two treatments, 1− pit − pis > 0 and, consequently, (5) holds
only when βt(z) = βs(z) = 0 for every z, i.e., X is uncorrelated with the potential responses Y
(t)
and Y (s) after conditioning on Z so that adjusting for X is unnecessary. When there are only two
treatments, (5) also holds if pit = pis = 1/2 and βt(z) = −βs(z) for every z. An example is given in
§4.
Note that β̂(z) used in θ̂B ignores the fact that cov(X,Y
(t) | Z = z) may depend on treatment
t. That is why θ̂B is asymptotically not as efficient as θ̂A in general, and σ
2
B = σ
2
A when these
covariances are the same for every t and every z, i.e., β1(z) = · · · = βk(z). An exceptional case
is that σ2A = σ
2
B when there are only two treatments and pit = pis = 1/2. In fact, θ̂B may be
asymptotically less efficient than θ̂, i.e., covariate adjustment with only the main effects may hurt
efficiency, a perspective in Freedman (2008) and Lin (2013). For example, there are scenarios in
which (5) holds but (6) does not. Simulation examples are given in §4, where comparisons of θ̂, θ̂A,
and θ̂B are made.
To make model free inference on the average treatment effect θ defined in (1), we only need to
apply Theorem 1 and construct consistent estimators of limiting variances σ2U , σ
2
A, σ
2
B , and σ
2
V . Let
S2t (z) be the sample variance of Yi’s in the group of patients under treatment t with Zi = z, S
2
t,A(z)
be S2t (z) with Yi replaced by Yi − XTi β̂t(z), S2t,B(z) be S2t (z) with Yi replaced by Yi − XTi β̂(z),
and Σ̂(z) be the sample covariance matrix of Xi’s within Zi = z. It is shown in the Supplementary
Material that, under (C1)-(C3), the following estimators are consistent for σ2U , σ
2
V , σ
2
A, and σ
2
B ,
respectively,
σ̂2U =
∑
z∈Z
n(z)
n
{
S2t (z)
pit
+
S2s (z)
pis
}
, σ̂2V =
∑
z∈Z
n(z)
n
{
Y¯t(z)− Y¯s(z)
}2 − θ̂2,
σ̂2A =
∑
z∈Z
n(z)
n
[
S2t,A(z)
pit
+
S2s,A(z)
pis
+ {β̂t(z)− β̂s(z)}T Σ̂(z){β̂t(z)− β̂s(z)}
]
,
σ̂2B =
∑
z∈Z
n(z)
n
{
S2t,B(z)
pit
+
S2s,B(z)
pis
}
,
regardless of which type of covariate-adaptive randomization method is used. Note that σ̂2U for θ̂
is different from the estimator defined in (36) of Bugni et al. (2019).
4 Simulation Results
There are many publications on empirical studies under covariate-adaptive randomization in the
last four decades. Some recent results are in Senn et al. (2010), Kahan and Morris (2012), and Xu
et al. (2016).
To evaluate and compare our proposed estimators θ̂, θ̂A, and θ̂B in terms of estimation bias
and standard deviation, and to examine variance estimators and the related asymptotic confidence
intervals based on Theorem 1, we present some simulation results in this section. We consider two
covariates, i.e., W = (X1, X2), where X1 is binary with pr(X1 = 1) = 1/2 and, conditioned on X1,
X2 ∼ N(X1 − 0.5, 1). For the potential responses, we consider two treatments in cases I-III and
three treatments in case IV.
Case I: Y (1) |W ∼ N(4X1 + 2X2, 1), Y (2) |W ∼ N(ϕ+ 4X1 + 2X2, 1).
Case II: Y (1) |W ∼ N(4X1 − 2X2, 1), Y (2) |W ∼ N(ϕ+ 4X1 + 2X2, 1).
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Case III: Y (1) |W ∼ N(0.25 + 3X1 + 0.2X22 , X1 + 0.5), Y (2) |W ∼ N(ϕ+ 4X1 + 2X2, 1).
Case IV: Y (3) |W ∼ N(ψ+ 1 + 2X1−X2, 1), and Y (1) and Y (2) are the same as those in case III.
We use ϕ = ψ = 1 in the simulation, which does not affect the relative performance of estimators
and coverage probability of related confidence intervals.
Case I has homogeneous treatment effects; case II has treatment effect heterogeneity since the
effects of X2 on Y
(1) and Y (2) have different signs; case III has the most severe treatment effect
heterogeneity as Y (1) |W and Y (2) |W have very different distributions; case IV considers multiple
treatments.
We consider 3 different Z’s in covariate-adaptive randomization. The first one is Z = X1 with 2
levels, in which case the function of W not used in randomization but still related with the potential
responses is h(W ) = X2. The second one is Z = (X1, d2) with 4 levels, where d2 is the discretized
X2 with 2 categories (−∞, 0) and [0,∞), and h(W ) is the continuous value of X2 in (−∞, 0) or
(0,∞). The third one is Z = (X1, d4) with 8 levels, where d4 is the discretized X2 with 4 categories
(−∞,−0.8), [−0.8, 0), [0, 0.8), and [0.8,∞), and h(W ) is the continuous value of X2 in (−∞,−0.8),
(−0.8, 0), (0, 0.8), or (0.8,∞). In any case, X = X2 is equivalent to h(W ) and is used covariate
adjustment.
For the randomization method, we consider minimization with treatment allocation 1:1 or 1:2
for cases I-III, and 1:2:2 for case IV. Simulation results for two other randomization methods,
the stratified permuted block randomization and the stratified urn design can be found in the
Supplementary Material.
We consider the total sample size n = 100 or 500. For these sample sizes, the smallest possible
expected numbers of patients within a stratum and treatment according to number of Z levels
are given in Table 3. It can be seen that when n = 100 and Z = (X1, d4) has 8 levels, with
non-negligible probability, the number of patients in some stratum-treatment combination is fewer
than 2 and thus calculation of estimators in (2)-(4) and their variance estimators are not possible.
Therefore, for cases I-III, we omit the scenario with n = 100 and Z = (X1, d4). For case IV, we
focus on n = 500 and Z = (X1, d2).
Tables 1-2 report the bias, standard deviation (SD), average estimated SD (SE), and coverage
probability (CP) of asymptotic 95% confidence interval, estimate ±1.96 SE, of θ̂, θ̂A, and θ̂B for
cases I-IV. Every scenario is evaluated with 2,000 simulation runs. The following is a summary of
the results in Tables 1-2.
1. All estimators have negligible biases that are smaller than 1% in most cases.
2. The variance estimators or SE’s are very accurate so that the coverage probabilities of confi-
dence intervals are adequate, except for a few cases with n = 100 and four Z categories.
3. With homogeneous treatment effects in case I, a more informative Z leads to a more efficient
θ̂. However, the same phenomenon may not exist when treatment effect heterogeneity exists,
though a more informative Z does not lead to a less efficient θ̂.
4. Adjusting for covariates, i.e., using θ̂A or θ̂B , may lead to substantial improvements over θ̂
in terms of SD, which again agrees with our theory. The improvement is larger when a less
informative Z is utilized in randomization, such as Z = X1. Another interesting observation
is that different Z used in randomization does not affect very much the SD of θ̂A or θ̂B .
5. The comparison of θ̂A and θ̂B is also consistent with our theory in §3. Under 1:1 treatment
allocation or homogeneous treatment effects, θ̂B is as good as θ̂A and sometimes slightly
better in finite sample performance. When treatment allocation is 1:2 and treatment effect
heterogeneity exists, θ̂B is not as good as θ̂A and could be even worse than θ̂. The same is
observed when treatment allocation is 1:2:2.
6. In case II with 1:1 treatment allocation, cov(X,Y (2) | Z = z) = −cov(X,Y (1) | Z = z), i.e.,
(5) holds and, thus, θ̂ and θ̂A have very similar SD’s, as predicted by Theorem 2. In this
particular case, θ̂B is also as good as θ̂A.
7. θ̂A has large SD and low CP when some stratum-treatment combinations have small number
of patients, such as the case of n = 100 and Z = (X1, d2) with 4 levels when treatment
allocation is 1:2. However, even if the smallest expected number of patients is as small as 7.7
in the case of n = 100, Z having 4 levels, and 1:1 treatment allocation, θ̂A performs well.
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5 A Real Data Example
In this section, we illustrate our methods by a real data example from Chong et al. (2016) whose goal
is to evaluate the contribution of low dietary iron intake to human capital attainment by measuring
the causal effect of reducing adolescent anemia on school attainment. The dataset is publicly avail-
able at https://www.openicpsr.org/openicpsr/project/113624/version/V1/view. In brief,
Chong et al. (2016) conducted an experiment on adolescents aged from 11 to 19 in rural Peru
(Cajamarca) where the burden of iron deficiency is high, to study whether a low-cost intervention
can encourage students to increase their iron intake and hence improve their school performance.
A stratified permuted block randomization design was applied to assign n = 219 students to one of
the following three promotional videos, considered as three treatments, with treatment allocation
1:1:1. The first video shows a popular soccer player encouraging iron supplements to maximize
energy; the second video shows a physician encouraging iron supplements for overall health; and
the third “placebo” video shows a dentist encouraging oral hygiene without mentioning iron at all.
The strata are student’s school grades Z ∈ Z = {1, 2, 3, 4, 5}. Chong et al. (2016) studied a variety
of outcomes regarding cognitive function, school performance, and aspirations. As an example, we
focus on the outcome of academic achievement, which is a standardized average of a students aca-
demic grades from the fall semester in subjects of math, foreign language, social sciences, science,
and communications. The same outcome is also used by Bugni et al. (2019) in an example.
Estimates θ̂, θ̂A, and θ̂B and their SE’s are reported in Table 4 for the average treatment effect
between the soccer player and placebo videos, or physician and placebo videos, together with the
p-values associated with two-sided tests of no treatment effect. The estimates from θ̂ are the same
as those in Bugni et al. (2019). The covariate X used in θ̂A and θ̂B is the baseline anemia status
thought to have interactive effect with treatment on the outcome, as mentioned in Chong et al.
(2016). It can be seen that the SE of θ̂A is the smallest and, in terms of p-values, the effect between
physician and placebo videos is only marginally significant when θ̂ is used, but very significant
based on θ̂A.
6 Recommendations and Discussions
To improve asymptotic efficiency, we recommend θ̂A in (3) since it is asymptotically better than θ̂
in (2) or θ̂B in (4). In the special case of two treatment arms with equal allocation, we recommend
θ̂B , since it is asymptotically equivalent to θ̂A and has better empirical performance.
As full stratification according to Z is required, one limitation of estimators in (2)-(4) is that
all strata need to have large enough sizes, at least 10 per stratum and treatment combination (Ye
and Shao 2020). Note that both covariate-adaptive randomization in treatment assignment and
adjustment for covariates in estimation can gain efficiency, and covariate-adaptive randomization
has an additional practically important advantage of balancing assignments across prognostic fac-
tors. Thus, how to choose Z and X is an important future research. It is also interesting to study
estimators by combining strata of small sizes.
Supplementary Material
Supplementary material contains all technical proofs and more simulation results.
9
Table 1: Bias, standard deviation (SD), average estimated SD (SE), and coverage probability (CP) of
95% asymptotic confidence interval under minimization for cases I-III
treatment allocation 1:1 treatment allocation 1:2
n case Z estimator bias SD SE CP bias SD SE CP
500 I X1 θ̂ -0.0038 0.1980 0.1999 0.9590 0.0070 0.2159 0.2124 0.9465
θ̂B -0.0016 0.0909 0.0893 0.9445 0.0016 0.0954 0.0949 0.9510
θ̂A -0.0016 0.0908 0.0893 0.9445 0.0017 0.0954 0.0948 0.9490
X1, d2 θ̂ -0.0029 0.1492 0.1466 0.9450 -0.0013 0.1537 0.1553 0.9560
θ̂B -0.0017 0.0900 0.0893 0.9455 -0.0011 0.0962 0.0947 0.9440
θ̂A -0.0018 0.0901 0.0894 0.9455 -0.0009 0.0965 0.0945 0.9435
X1, d4 θ̂ 0.0005 0.1143 0.1150 0.9560 0.0003 0.1237 0.1219 0.9485
θ̂B 0.0010 0.0903 0.0893 0.9505 0.0013 0.0967 0.0946 0.9425
θ̂A 0.0007 0.0908 0.0893 0.9500 0.0010 0.0990 0.0944 0.9415
II X1 θ̂ 0.0085 0.2212 0.2191 0.9480 0.0067 0.2320 0.2303 0.9505
θ̂B 0.0086 0.2222 0.2185 0.9495 0.0063 0.2563 0.2541 0.9430
θ̂A 0.0086 0.2214 0.2191 0.9500 0.0078 0.2255 0.2212 0.9470
X1, d2 θ̂ 0.0084 0.2201 0.2191 0.9480 0.0076 0.2284 0.2251 0.9465
θ̂B 0.0076 0.2214 0.2178 0.9440 0.0078 0.2407 0.2344 0.9350
θ̂A 0.0085 0.2204 0.2190 0.9475 0.0077 0.2242 0.2212 0.9450
X1, d4 θ̂ 0.0057 0.2222 0.2192 0.9440 0.0104 0.2256 0.2230 0.9405
θ̂B 0.0061 0.2233 0.2177 0.9425 0.0108 0.2289 0.2254 0.9420
θ̂A 0.0057 0.2221 0.2190 0.9430 0.0101 0.2252 0.2211 0.9420
III X1 θ̂ 0.0003 0.1716 0.1731 0.9475 0.0072 0.1691 0.1667 0.9425
θ̂B 0.0029 0.1495 0.1477 0.9500 0.0048 0.1675 0.1656 0.9475
θ̂A 0.0031 0.1496 0.1479 0.9480 0.0081 0.1546 0.1533 0.9465
X1, d2 θ̂ 0.0016 0.1580 0.1593 0.9490 0.0032 0.1603 0.1595 0.9465
θ̂B 0.0050 0.1468 0.1470 0.9460 0.0061 0.1621 0.1576 0.9420
θ̂A 0.0032 0.1464 0.1474 0.9480 0.0052 0.1559 0.1523 0.9440
X1, d4 θ̂ 0.0042 0.1528 0.1525 0.9465 0.0049 0.1601 0.1557 0.9405
θ̂B 0.0080 0.1495 0.1468 0.9425 0.0094 0.1577 0.1539 0.9395
θ̂A 0.0048 0.1493 0.1474 0.9450 0.0069 0.1573 0.1521 0.9410
100 I X1 θ̂ 0.0111 0.4441 0.4486 0.9545 0.0066 0.4609 0.4747 0.9580
θ̂B 0.0038 0.2035 0.1982 0.9425 -0.0017 0.2114 0.2092 0.9490
θ̂A 0.0038 0.2035 0.1983 0.9425 -0.0014 0.2126 0.2083 0.9485
X1, d2 θ̂ 0.0108 0.3316 0.3305 0.9425 0.0034 0.3475 0.3501 0.9490
θ̂B 0.0029 0.2021 0.1981 0.9465 0.0016 0.2181 0.2092 0.9365
θ̂A 0.0013 0.2148 0.2013 0.9440 -0.0035 0.4016 0.2190 0.9140
II X1 θ̂ -0.0057 0.4857 0.4902 0.9515 -0.0143 0.5131 0.5157 0.9445
θ̂B -0.0044 0.4958 0.4828 0.9420 -0.0152 0.5710 0.5612 0.9405
θ̂A -0.0049 0.4878 0.4894 0.9500 -0.0101 0.4965 0.4943 0.9455
X1, d2 θ̂ -0.0062 0.4874 0.4904 0.9495 -0.0102 0.5013 0.5031 0.9545
θ̂B -0.0077 0.4981 0.4774 0.9355 -0.0096 0.5400 0.5114 0.9305
θ̂A -0.0076 0.4906 0.4904 0.9455 -0.0147 0.5993 0.4999 0.9390
III X1 θ̂ 0.0003 0.3855 0.3869 0.9475 -0.0074 0.3729 0.3717 0.9470
θ̂B 0.0050 0.3349 0.3266 0.9410 -0.0052 0.3744 0.3649 0.9365
θ̂A 0.0047 0.3314 0.3291 0.9465 0.0045 0.3486 0.3390 0.9400
X1, d2 θ̂ -0.0004 0.3541 0.3566 0.9445 -0.0054 0.3572 0.3569 0.9510
θ̂B 0.0104 0.3313 0.3236 0.9425 0.0084 0.3663 0.3445 0.9305
θ̂A 0.0015 0.3315 0.3298 0.9435 0.0003 0.5643 0.3456 0.9310
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Table 2: Bias, standard deviation (SD), average estimated SD (SE), and coverage probability (CP)
of 95% asymptotic confidence interval under minimization for case IV with n = 500
t s θ estimator bias SD SE CP
2 1 1 θ̂ -0.0007 0.1907 0.1901 0.9515
θ̂B 0.0040 0.1840 0.1821 0.9470
θ̂A 0.0058 0.1777 0.1726 0.9375
3 1 1 θ̂ -0.0004 0.1541 0.1546 0.9445
θ̂B 0.0037 0.1616 0.1615 0.9445
θ̂A 0.0052 0.1479 0.1460 0.9395
3 2 0 θ̂ 0.0004 0.2094 0.2082 0.9505
θ̂B -0.0002 0.2077 0.2048 0.9445
θ̂A -0.0006 0.2019 0.2007 0.9495
Table 3: Smallest expected number of patients among all stratum-treatment combinations
n Z number of levels 1:1 allocation 1:2 allocation 1:2:2 allocation
100 X1 2 25.0 16.7 10.0
X1, d2 4 7.7 5.1 3.1
X1, d4 8 2.4 1.6 1.0
500 X1 2 125 83.3 50
X1, d2 4 38.6 25.7 15.4
X1, d4 8 12.1 8.1 4.8
Table 4: Results from real data analysis
soccer versus placebo physician versus placebo
estimator estimate SE p-value estimate SE p-value
θ̂ -0.051 0.205 0.803 0.409 0.207 0.048
θ̂B -0.089 0.203 0.661 0.444 0.202 0.028
θ̂A -0.048 0.199 0.807 0.480 0.198 0.015
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Supplementary Material
Technical Proofs
Proof of Theorem 1
Asymptotics for θ̂: We start with deriving the asymptotic distribution of θ̂. As mentioned in the
main article, the key in this proof is decomposing θ̂ − θ as the sum of U and V , where
U =
∑
z∈Z
n(z)
n
[
{Y¯t(z)− Y¯s(z)} − {E(Y (t) | Z = z)− E(Y (s) | Z = z)}
]
, (S1)
V =
∑
z∈Z
n(z)
n
{E(Y (t) | Z = z)− E(Y (s) | Z = z)} − θ. (S2)
Let D = (Z1, . . . , Zn, I1, . . . , In), I(A) be the indicator function of event A, and nt(z) =∑n
i=1 I(Ii = et, Zi = z) be the number of patients within stratum Zi = z and treatment t. Under
(C1)-(C3), n(z), nt(z), and ns(z) are functions of D and the conditional expectation E{Y¯t(z) | D}
is equal to E(Y (t) | Z = z), which implies that E(U | D) = 0 a.s. and E(U) = 0. Note that
V =
1
n
∑
z∈Z
n∑
i=1
[
I(Zi = z){E(Y (t) | Z = z)− E(Y (s) | Z = z)}
]
− θ
=
1
n
n∑
i=1
[∑
z∈Z
I(Zi = z){E(Y (t) | Z = z)− E(Y (s) | Z = z)}
]
− θ
=
1
n
n∑
i=1
E(Y
(t)
i − Y (s)i | Zi)− θ
Hence, E(V ) = 0 and consequently E(θ̂) = θ, which establishes the unbiasedness of θ̂.
Next, we establish the asymptotic normality of θ̂. From the previous derivations of V , V is
simply an average of independent and identically distributed terms and from the Central Limit
Theorem, √
nV
d−→ N(0, σ2V ).
We now turn to U . Notice that Ii’s are involved in U , which results in complicated dependence and is
the major difficulty in deriving the asymptotic distribution of U . A useful technique that can largely
simplify the problem is to derive the distribution of U conditional on D = (Z1, . . . , Zn, I1, . . . , In).
We define
U(z) =
n(z)
n
[
{Y¯t(z)− Y¯s(z)} − {E(Y (t) | Z = z)− E(Y (s) | Z = z)}
]
so that U =
∑
z∈Z U(z). From the fact that E{U(z) | D} = 0 a.s. and Lindeberg’s Central Limit
Theorem, we conclude that, for every z, as n→∞,
U(z)√
var{U(z) | D} | D
d−→ N(0, 1).
The Lindeberg’s condition will be verified at the end.
Next, we prove that cov{Y¯t(z) − Y¯s(z), Y¯t(z′) − Y¯s(z′) | D} = 0 a.s. for z 6= z′. By definition
this conditional covariance is equal to
1
cov
[
n∑
i=1
I(Zi = z)
{
I(Ii = et)Y (t)i
nt(z)
− I(Ii = es)Y
(s)
i
ns(z)
}
,
n∑
j=1
I(Zj = z′)
{
I(Ij = et)Y (t)j
nt(z′)
− I(Ij = es)Y
(s)
j
ns(z′)
}
| D

=
n∑
i=1
n∑
j=1
I(Zi = z)I(Zj = z′) cov
{
I(Ii = et)Y (t)i
nt(z)
− I(Ii = es)Y
(s)
i
ns(z)
,
I(Ij = et)Y (t)j
nt(z′)
− I(Ij = es)Y
(s)
j
ns(z′)
| D
}
because {Zi, i = 1, . . . , n} ⊂ D. When i = j, I(Zi = z)I(Zi = z′) = 0 for z 6= z′. When i 6= j, the
terms are also equal to zero because cov(Y
(`)
i , Y
(m)
j | D) = 0 a.s. for `,m = 1, . . . , k from (C1)-(C2).
From the definition of U(z), this also proves that cov{U(z), U(z′) | D} = 0 a.s. for z 6= z′. Then, it
follows from the delta method that
U√∑
z∈Z var{U(z) | D}
| D d−→ N(0, 1).
From the bounded convergence theorem, this result still holds unconditionally, i.e.,
U√∑
z∈Z var{U(z) | D}
d−→ N(0, 1).
Note that
n
∑
z∈Z
var{U(z) | D}
=
∑
z∈Z
n2(z)
n
var
{
1
nt(z)
∑
i:Zi=z
I(Ii = et)Y (t)i −
1
ns(z)
∑
i:Zi=z
I(Ii = es)Y (s)i | D
}
=
∑
z∈Z
n2(z)
n
var
{ ∑
i:Zi=z
I(Ii = et)Y (t)i
nt(z)
− I(Ii = es)Y
(s)
i
ns(z)
| D
}
=
∑
z∈Z
n2(z)
n
∑
i:Zi=z
var
{
I(Ii = et)Y (t)i
nt(z)
− I(Ii = es)Y
(s)
i
ns(z)
| D
}
=
∑
z∈Z
n2(z)
n
∑
i:Zi=z
{
I(Ii = et)var(Y (t)i | Zi)
n2t (z)
+
I(Ii = es)var(Y (s)i | Zi)
n2s(z)
}
=
∑
z∈Z
n(z)
n
{
n(z)
nt(z)
var(Y (t) | Z = z) + n(z)
ns(z)
var(Y (s) | Z = z)
}
=
∑
z∈Z
pr(Z = z)
{
1
pit
var(Y (t) | Z = z) + 1
pis
var(Y (s) | Z = z)
}
+ op(1)
= E
{
1
pit
var(Y (t) | Z) + 1
pis
var(Y (s) | Z)
}
+ op(1)
= σ2U + op(1)
where the first equality is because n(z) is a function ofD, the third equality is because the summands
are mutually independent conditional on D, the fourth equality is from (C1)-(C2), the sixth equality
is because n(z)/n = pr(Z = z) + op(1), and from (C2)-(C3), nt(z)/n(z) = n(z)
−1Dt(z) + pit =
2
pit + op(1) for every t. From Slutsky’s theorem, this proves that as n→∞,
√
nU/σU
d−→ N(0, 1).
Combining the results for U and V and using the fact that U and V are uncorrelated because
E(UV ) = E{V E(U | D)} = 0, we conclude that the results for θ̂ hold.
For completeness, we verify the Lindeberg’s condition, by rearranging U(z) as
U(z) =
n∑
i=1
(K
(t)
i −K(s)i ), K(t)i =
n(z)
n
I(Ii = et, Zi = z)
nt(z)
{Y (t)i − E(Y (t) | Zi = z)}
We have already shown that E(K
(t)
i −K(s)i | D) = 0 and
var(K
(t)
i −K(s)i | D)
=
n2(z)
n2n2t (z)
I(Ii = et, Zi = z)var(Y (t) | Z = z) + n
2(z)
n2n2s(z)
I(Ii = es, Zi = z)var(Y (s) | Z = z).
Then, the Lindeberg’s condition holds because for any  > 0,
n∑
i=1
E
[
(K
(t)
i −K(s)i )2
var(U(z) | D) I
{
(K
(t)
i −K(s)i )2
var(U(z) | D) > 
}
| D
]
=
n∑
i=1
var(K
(t)
i −K(s)i | D)
var(U(z) | D) E
[
(K
(t)
i −K(s)i )2
var(K
(t)
i −K(s)i | D)
I
{
(K
(t)
i −K(s)i )2
var(U(z) | D) > 
}
| D
]
≤ max
i
E
[
(K
(t)
i −K(s)i )2
var(K
(t)
i −K(s)i | D)
I
{
(K
(t)
i −K(s)i )2
var(K
(t)
i −K(s)i | D)
> 
var(U(z) | D)
var(K
(t)
i −K(s)i | D)
}
| D
]
= o(1)
where the third line is because
∑n
i=1 var(K
(t)
i − K(s)i | D) = var(U(z) | D), and the last line
is because K
(t)
i − K(s)i /
√
var(K
(t)
i −K(s)i | D) has zero expectation and unit variance, and that
maxi var(K
(t)
i −K(s)i | D)/var(U(z) | D) ≤ max({nt(z)}−1, {ns(z)}−1) = o(1).
Asymptotics for θ̂A, θ̂B : To establish the results for θ̂A and θ̂B , we need the following lemma
about the asymptotic limits of β̂t(z) used in θ̂A and β̂(z) used in θ̂B .
Lemma 1. Under the conditions of Theorem 1, β̂t(z) = βt(z) + op(1) and β̂(z) = β(z) + op(1), for
every z ∈ Z, where βt(z) and β(z) are defined in Theorem 1.
of Lemma 1. We prove the result for β̂t(z). The proof for β̂(z) is analogous and omitted. The
numerator of β̂t(z) equals
n∑
i=1
I(Ii = et, Zi = z)XiYi − 1
nt(z)
n∑
i=1
I(Ii = et, Zi = z)Xi
n∑
i=1
I(Ii = et, Zi = z)Yi
Conditional on D, the first term is an average of independent random variables. Assuming (C2)
and existence of the second moment of XY (t), by the weak law of large numbers for independent
random variables, we conclude that, for any  > 0,
lim
n→∞pr
{
1
n
|
n∑
i=1
I(Ii = et, Zi = z)XiYi − nt(z)E(XY (t) | Z = z) |≥  | D
}
= 0,
which together with the bounded convergence theorem and nt(z)/n = pitpr(Z = z) + op(1) by (C3)
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implies that
1
nt(z)
n∑
i=1
I(Ii = et, Zi = z)XiYi = E(XY (t) | Z = z) + op(1).
Similarly, we can show the result with XiYi replaced by Xi or Yi and, therefore,
1
nt(z)
n∑
i=1
I(Ii = et, Zi = z)XiYi − 1
n2t (z)
n∑
i=1
I(Ii = et, Zi = z)Xi
n∑
i=1
I(Ii = et, Zi = z)Yi
= {E(XY (t) | Z = z) + op(1)} − {E(X | Z = z) + op(1)}{E(Y (t) | Z = z) + op(1)}
= cov(X,Y (t) | Z = z) + op(1).
The denominator of β̂t(z) can be treated similarly, which leads to
1
nt(z)
∑
i:Ii=et,Zi=z
{Xi − X¯t(z)}{Xi − X¯t(z)}T = var(X | Z = z) + op(1).
The proof is completed by using the definition of βt(z).
Next, consider θ̂B . Let
UB =
∑
z∈Z
n(z)
n
[
Y¯t(z)− Y¯s(z)− {X¯t(z)− X¯s(z)}Tβ(z)− {E(Y (t) | Z = z)− E(Y (s) | Z = z)}
]
Similar to the decomposition for θ̂−θ in (S1)-(S2), we have the following decomposition for θ̂B−θ:
θ̂B − θ = UB + V −
∑
z∈Z
n(z)
n
{X¯1(z)− X¯0(z)}T {β̂(z)− β(z)}
The last term is op(n
−1/2) because β̂(z)−β(z) = op(1) by Lemma 1 and X¯1(z)−X¯0(z) = Op(n−1/2)
that can be shown using a similar technique in the proof of θ̂. To derive the asymptotic distribution
of UB , we apply the same techniques used to treat U in the proof of θ̂, i.e., conditioned on D, UB
can be shown to be an average of independent terms so that conditioned on D, UB is asymptotically
normal and, therefore, unconditionally it is also asymptotically normal. Since E(UB | D) = 0, it
remains to find the conditional variance of UB given D, which is
var(
√
nUB | D) =
∑
z∈Z
n(z)
n
[
n(z)
nt(z)
var{Y (t) −XTβ(z) | Z = z}+ n(z)
ns(z)
var{Y (s) −XTβ(z) | Z = z}
]
= E
[
1
pit
var{Y (t) −XTβ(Z) | Z}+ 1
pis
var{Y (s) −XTβ(Z) | Z}
]
+ op(1)
= σ2B + op(1)
This completes the proof of θ̂B .
Next, we consider θ̂A. Define
UA =
∑
z∈Z
n(z)
n
∑
`=t,s
(−1)`=s
[
Y¯`(z)− {X¯`(z)− X¯(z)}Tβ`(z)− E(Y (`) | Z = z)
]
Then,
θ̂A − θ = UA + V −
∑
z∈Z
n(z)
n
∑
`=t,s
(−1)`=s{(X¯`(z)− X¯(z)}T {β̂`(z)− β`(z)}
where the last term is op(n
−1/2) because β̂t(z) − βt(z) = op(1) by Lemma 1 and X¯j(z) − X¯(z) =
Op(n
−1/2). It remains to derive the asymptotic distribution of UA. Consider a further decomposi-
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tion
UA = UA1 + UA2
where
UA1 =
∑
z∈Z
n(z)
n
∑
`=t,s
(−1)`=s[Y¯`(z)− E(Y (`) | Z = z)− {X¯`(z)− E(X | Z = z)}Tβ`(z)]
UA2 =
∑
z∈Z
n(z)
n
{X¯(z)− E(X | Z = z)}T {βt(z)− βs(z)}
and cov(UA1, UA2 | D) = E(UA1UA2 | D) = 0, which can be seen from cov{Y (t)i − Xiβt(z), Xj |
Zi = z, Zj} = 0 a.s. for any j, i = 1, . . . , n, and t = 1, . . . , k. The asymptotic normality of UA1 can
be derived in the same way as that for UB with E(UA1 | D) = 0 and
var(
√
nUA1 | D) = E
[
1
pit
var{Y (t) −XTβt(z) | Z}+ 1
pis
var{Y (s) −XTβs(z) | Z}
]
+ op(1).
Note that UA2 is an average of independent and identically distributed terms and its asymptotic
normality follows directly from the Central Limit Theorem. Specifically,
√
nUA2 converges in
distribution to normal with mean 0 and variance E
[{βt(Z)− βs(Z)}Tvar(X | Z){βt(Z)− βs(Z)}] .
This proves the first result for θ̂A because the sum of the asymptotic variances of UA1 and UA2 is
exactly σ2A. The proof is completed.
Proof of Theorem 2
Define Σ(z) = var(X | Z = z),
σ2A(z) =
var(Y (t) −XTβt(z) | Z = z)
pit
+
var(Y (s) −XTβs(z) | Z = z)
pis
+ {βt(z)− βs(z)}TΣ(z){βt(z)− βs(z)}
σ2U (z) =
var(Y (t) | Z = z)
pit
+
var(Y (s) | Z = z)
pis
Then σ2A =
∑
z∈Z pr(Z = z)σ
2
A(z) and σ
2
U =
∑
z∈Z pr(Z = z)σ
2
U (z). Hence, the result for σ
2
U − σ2A
follows from
σ2A(z)− σ2U (z)
=
{βt(z)}TΣ(z)βt(z)− 2cov(XTβt(z), Y (t) | Z = z)
pit
+
{βs(z)}TΣ(z)βs(z)− 2cov(XTβs(z), Y (s) | Z = z)
pis
+ {βt(z)− βs(z)}TΣ(z){βt(z)− βs(z)}
=
{βt(z)}TΣ(z)βt(z)− 2{βt(z)}TΣ(z)βt(z)
pit
+
{βs(z)}TΣ(z)βs(z)− 2{βs(z)}TΣ(z)βs(z)
pis
+ {βt(z)− βs(z)}TΣ(z){βt(z)− βs(z)}
= − {βt(z)}
TΣ(z)βt(z)
pit
− {βs(z)}
TΣ(z)βs(z)
pis
+ {βt(z)− βs(z)}TΣ(z){βt(z)− βs(z)}
= − {pisβt(z) + pitβs(z)}
TΣ(z){pisβt(z) + pitβs(z)}
pitpis(pit + pis)
− {βt(z)− βs(z)}TΣ(z){βt(z)− βs(z)}
(
1− pit − pis
pit + pis
)
where the second equality follows from βt(z) = Σ(z)
−1cov(X,Y (t) | Z = z). This also proves that
σ2A ≤ σ2U , because Σ(z) is positive definite for every z and pit + pis ≤ 1. If σ2A = σ2U , then we must
have pisβt(z) + pitβs(z) = 0 and (1− pit − pis){βt(z)− βs(z)} = 0 for every z, which is the same as
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(5).
To show the result for σ2B − σ2A , note that σ2B =
∑
z∈Z pr(Z = z)σ
2
B(z), where
σ2B(z) =
var{Y (t) −XTβ(z) | Z = z}
pit
+
var{Y (s) −XTβ(z) | Z = z}
pis
=
var{Y (t) −XTβt(z) +XTβt(z)−XTβ(z) | Z = z}
pit
+
var{Y (s) −XTβs(z) +XTβs(z)−XTβ(z) | Z = z}
pis
=
var{Y (t) −XTβt(z) | Z = z}+ var{XTβt(z)−XTβ(z) | Z = z}
pit
+
var{Y (s) −XTβs(z) | Z = z}+ var{XTβs(z)−XTβ(z) | Z = z}
pis
where the second equality is because
cov{Y (t) − βt(z)TX,βt(z)TX − β(z)TX | Z = z}
= cov{Y (t) − βt(z)TX,X | Z = z}{βt(z)− β(z)}
= {cov(Y (t), X | Z = z)− βt(z)Tvar(X | Z = z)}{βt(z)− β(z)} = 0
Then,
σ2A(z)− σ2B(z) = {βt(z)− βs(z)}TΣ(z){βt(z)− βs(z)}
− {βt(z)− β(z)}
TΣ(z){βt(z)− β(z)}
pit
− {βs(z)− β(z)}
TΣ(z){βs(z)− β(z)}
pis
In order to show that σ2A(z) − σ2B(z) ≤ 0 for every z, we prove a stronger statement: for each
given z, it is true that for any β˜(z),
{βt(z)− βs(z)}TΣ(z){βt(z)− βs(z)}
− {βt(z)− β˜(z)}
TΣ(z){βt(z)− β˜(z)}
pit
− {βs(z)− β˜(z)}
TΣ(z){βs(z)− β˜(z)}
pis
≤ 0. (S3)
As a consequence, setting β˜(z) as β(z) =
∑
t pitβt(z), the statement in (S3) also holds. This proves
σ2A(z)− σ2B(z) ≤ 0.
In what follows, we prove the claim in (S3). For each given z, the gradient of the left hand side
of (S3) is
−2
[
{β˜(z)− βt(z)}TΣ(z)
pit
+
{β˜(z)− βs(z)}TΣ(z)
pis
]
,
which equals zero when β˜(z) = {pisβt(z) +pitβs(z)}/(pit+pis). This is also the unique solution from
the positive definiteness of Σ(z). It is also easy to see that the Hessian of the left hand side of (S3)
is negative definite, which means that β˜(z) = {pisβt(z)+pitβs(z)}/(pit+pis) is the global and unique
maximizer of the left hand side of (S3). The statement in (S3) is true because when evaluated at
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β˜(z) = {pisβt(z) + pitβs(z)}/(pit + pis), the left hand side of (S3) equals
{βt(z)− βs(z)}TΣ(z){βt(z)− βs(z)}
−
{
βt(z)− pisβt(z) + pitβs(z)
pit + pis
}T
Σ(z)
{
βt(z)− pisβt(z) + pitβs(z)
pit + pis
}
1
pit
−
{
βs(z)− pisβt(z) + pitβs(z)
pit + pis
}T
Σ(z)
{
βs(z)− pisβt(z) + pitβs(z)
pit + pis
}
1
pis
=− {βt(z)− βs(z)}TΣ(z){βt(z)− βs(z)}
(
1− pit − pis
pit + pis
)
≤ 0
This completes the proof for σ2A ≤ σ2B , where the equality holds if and only if {βt(z)− βs(z)}(1−
pit − pis) = 0 and
∑k
`=1 pi`β`(z) = {pisβt(z) + pitβs(z)}/(pit + pis) for every z, which is the same as
(6).
Proof of the Consistency of Variance Estimators
First, we prove the consistency of estimators σ̂2U , σ̂
2
V , σ̂
2
A and σ̂
2
B . For σ̂
2
U , following the same
arguments as in the proof of Lemma 1, we can show that
S2t (z) = var(Y
(t) | Z = z) + op(1)
From n(z)/n = pr(Z = z) + op(1), we conclude that σ̂
2
U = σ
2
U + op(1) by continuous mapping
theorem. For σ̂2V , following the same arguments as in the proof of Lemma 1, we conclude that
Y¯t(z) = E(Y
(t) | Z = z) + op(1),
which together with the fact that θ̂ = θ + op(1) implied by Theorem 1, we obtain that
σ̂2V =
∑
z∈Z
pr(Z = z)
{
E(Y (t) − Y (s) | Z = z)
}2
− θ2 + op(1)
= E
[{
E(Y (t) − Y (s) | Z)
}2]
− {E(Y (t) − Y (s))}2 + op(1)
= σ2V + op(1).
The proof for the consistency of σ̂2A and σ̂
2
B with β̂t(z), β̂(z) respectively replaced with βt(z), β(z)
is analogous and is omitted. From this, the consistency of σ̂2A and σ̂
2
B can be established using
Lemma 1.
Additional Simulation Results
Tables S1 and S2 report the bias, standard deviation (SD), average estimated SD (SE), and coverage
probability (CP) of asymptotic 95% confidence interval, estimate ±1.96 SE, of θ̂, θ̂A, and θ̂B for
cases I-III under stratified permuted block randomization and urn design, respectively, based on
2,000 simulation runs.
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Table S1: Bias, standard deviation (SD), average estimated SD (SE), and coverage probability (CP)
of 95% asymptotic confidence interval under Stratified Permuted Block Randomization for cases I-III
(block size = 4 for 1:1 allocation and block size = 6 for 1:2 allocation)
treatment allocation 1:1 treatment allocation 1:2
n case Z estimator bias SD SE CP bias SD SE CP
500 I X1 θ̂ 0.0042 0.2005 0.2000 0.9495 0.0011 0.2161 0.2124 0.9500
θ̂B 0.0016 0.0887 0.0894 0.9515 -0.0001 0.0967 0.0948 0.9480
θ̂A 0.0016 0.0887 0.0894 0.9520 0.0000 0.0969 0.0947 0.9495
X1, D2 θ̂ -0.0052 0.1473 0.1467 0.9455 0.0020 0.1552 0.1556 0.9530
θ̂B -0.0004 0.0907 0.0894 0.9430 0.0014 0.0966 0.0948 0.9445
θ̂A -0.0003 0.0908 0.0894 0.9430 0.0015 0.0964 0.0946 0.9440
X1, D4 θ̂ 0.0024 0.1121 0.1152 0.9520 0.0009 0.1256 0.1220 0.9420
θ̂B 0.0009 0.0884 0.0895 0.9430 -0.0026 0.0992 0.0947 0.9360
θ̂A 0.0009 0.0885 0.0895 0.9465 -0.0025 0.1002 0.0944 0.9320
II X1 θ̂ 0.0004 0.2168 0.2191 0.9505 0.0030 0.2329 0.2304 0.9400
θ̂B 0.0002 0.2173 0.2184 0.9485 0.0029 0.2600 0.2543 0.9415
θ̂A 0.0005 0.2169 0.2190 0.9510 0.0034 0.2247 0.2214 0.9405
X1, D2 θ̂ 0.0039 0.2199 0.2190 0.9500 0.0006 0.2275 0.2255 0.9405
θ̂B 0.0037 0.2207 0.2177 0.9500 0.0004 0.2393 0.2350 0.9410
θ̂A 0.0038 0.2203 0.2189 0.9490 0.0007 0.2241 0.2216 0.9440
X1, D4 θ̂ 0.0020 0.2131 0.2193 0.9570 -0.0046 0.2246 0.2230 0.9465
θ̂B 0.0021 0.2140 0.2176 0.9515 -0.0058 0.2314 0.2253 0.9415
θ̂A 0.0017 0.2130 0.2190 0.9560 -0.0034 0.2239 0.2211 0.9405
III X1 θ̂ 0.0046 0.1737 0.1732 0.9500 0.0028 0.1674 0.1666 0.9465
θ̂B 0.0048 0.1485 0.1477 0.9490 0.0037 0.1688 0.1656 0.9395
θ̂A 0.0049 0.1484 0.1479 0.9500 0.0057 0.1550 0.1532 0.9455
X1, D2 θ̂ 0.0028 0.1615 0.1593 0.9450 0.0016 0.1620 0.1597 0.9455
θ̂B 0.0083 0.1501 0.1471 0.9425 0.0044 0.1626 0.1579 0.9380
θ̂A 0.0064 0.1499 0.1475 0.9440 0.0039 0.1562 0.1526 0.9380
X1, D4 θ̂ 0.0033 0.1500 0.1527 0.9540 -0.0012 0.1565 0.1560 0.9500
θ̂B 0.0062 0.1450 0.1469 0.9515 0.0001 0.1586 0.1540 0.9410
θ̂A 0.0031 0.1448 0.1475 0.9520 -0.0006 0.1558 0.1521 0.9400
100 I X1 θ̂ -0.0019 0.4505 0.4484 0.9460 -0.0087 0.4690 0.4741 0.9500
θ̂B -0.0004 0.2004 0.1977 0.9350 0.0013 0.2132 0.2094 0.9420
θ̂A -0.0005 0.2004 0.1978 0.9365 0.0013 0.2147 0.2084 0.9395
X1, D2 θ̂ -0.0072 0.3305 0.3314 0.9500 -0.0043 0.3414 0.3498 0.9500
θ̂B -0.0003 0.2036 0.1983 0.9415 0.0018 0.2184 0.2094 0.9340
θ̂A -0.0017 0.2059 0.1997 0.9380 0.0054 0.2387 0.2113 0.9165
II X1 θ̂ 0.0151 0.4930 0.4901 0.9500 0.0167 0.5103 0.5140 0.9445
θ̂B 0.0136 0.4992 0.4827 0.9430 0.0230 0.5728 0.5607 0.9405
θ̂A 0.0149 0.4945 0.4892 0.9470 0.0152 0.4938 0.4929 0.9455
X1, D2 θ̂ 0.0112 0.4953 0.4916 0.9475 0.0209 0.5070 0.5035 0.9435
θ̂B 0.0085 0.5059 0.4781 0.9320 0.0223 0.5428 0.5130 0.9310
θ̂A 0.0102 0.4976 0.4907 0.9415 0.0226 0.5105 0.4951 0.9410
III X1 θ̂ 0.0033 0.3877 0.3869 0.9485 0.0016 0.3668 0.3714 0.9460
θ̂B 0.0110 0.3325 0.3262 0.9465 0.0175 0.3692 0.3651 0.9365
θ̂A 0.0116 0.3306 0.3287 0.9490 0.0212 0.3413 0.3390 0.9380
X1, D2 θ̂ -0.0006 0.3642 0.3578 0.9430 0.0071 0.3547 0.3575 0.9485
θ̂B 0.0163 0.3404 0.3241 0.9285 0.0240 0.3653 0.3456 0.9375
θ̂A 0.0079 0.3394 0.3296 0.9365 0.0256 0.3701 0.3400 0.9330
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Table S2: Bias, standard deviation (SD), average estimated SD (SE), and coverage probability (CP)
of 95% asymptotic confidence interval under Stratified Urn Design for cases I-III
treatment allocation 1:1 treatment allocation 1:2
n case Z estimator bias SD SE CP bias SD SE CP
500 I X1 θ̂ -0.0095 0.1984 0.2000 0.9465 0.0012 0.2119 0.2121 0.9470
θ̂B -0.0052 0.0866 0.0893 0.9585 -0.0012 0.0957 0.0948 0.9455
θ̂A -0.0052 0.0867 0.0893 0.9580 -0.0013 0.0957 0.0947 0.9445
X1, D2 θ̂ 0.0001 0.1486 0.1466 0.9430 0.0049 0.1560 0.1554 0.9510
θ̂B -0.0004 0.0902 0.0894 0.9405 0.0020 0.0948 0.0947 0.9440
θ̂A -0.0004 0.0902 0.0894 0.9420 0.0022 0.0953 0.0945 0.9435
X1, D4 θ̂ -0.0001 0.1160 0.1150 0.9470 0.0008 0.1216 0.1220 0.9520
θ̂B -0.0019 0.0927 0.0893 0.9390 -0.0013 0.0966 0.0947 0.9445
θ̂A -0.0018 0.0930 0.0894 0.9390 -0.0017 0.0993 0.0947 0.9405
II X1 θ̂ 0.0037 0.2196 0.2192 0.9510 -0.0040 0.2331 0.2305 0.9480
θ̂B 0.0033 0.2203 0.2186 0.9495 -0.0046 0.2596 0.2544 0.9465
θ̂A 0.0034 0.2196 0.2191 0.9495 -0.0034 0.2230 0.2214 0.9475
X1, D2 θ̂ 0.0083 0.2200 0.2191 0.9530 -0.0012 0.2261 0.2253 0.9450
θ̂B 0.0085 0.2216 0.2180 0.9465 -0.0015 0.2382 0.2346 0.9450
θ̂A 0.0082 0.2205 0.2190 0.9480 0.0001 0.2227 0.2213 0.9455
X1, D4 θ̂ 0.0071 0.2214 0.2193 0.9475 0.0068 0.2246 0.2230 0.9460
θ̂B 0.0080 0.2226 0.2176 0.9450 0.0068 0.2306 0.2254 0.9415
θ̂A 0.0068 0.2223 0.2190 0.9465 0.0066 0.2243 0.2213 0.9440
III X1 θ̂ -0.0037 0.1724 0.1731 0.9470 -0.0015 0.1659 0.1666 0.9530
θ̂B -0.0003 0.1480 0.1477 0.9495 -0.0014 0.1694 0.1657 0.9385
θ̂A -0.0002 0.1478 0.1479 0.9525 0.0008 0.1548 0.1533 0.9475
X1, D2 θ̂ 0.0029 0.1594 0.1593 0.9510 0.0013 0.1596 0.1594 0.9465
θ̂B 0.0052 0.1492 0.1470 0.9495 0.0029 0.1588 0.1576 0.9420
θ̂A 0.0031 0.1487 0.1474 0.9510 0.0028 0.1530 0.1523 0.9420
X1, D4 θ̂ 0.0012 0.1534 0.1525 0.9455 0.0032 0.1569 0.1558 0.9515
θ̂B 0.0049 0.1508 0.1468 0.9445 0.0060 0.1572 0.1539 0.9460
θ̂A 0.0014 0.1510 0.1473 0.9455 0.0039 0.1554 0.1521 0.9520
100 I X1 θ̂ 0.0216 0.4468 0.4487 0.9470 -0.0132 0.4801 0.4757 0.9460
θ̂B 0.0012 0.2033 0.1981 0.9365 -0.0070 0.2115 0.2103 0.9495
θ̂A 0.0014 0.2034 0.1982 0.9390 -0.0073 0.2145 0.2093 0.9420
X1, D2 θ̂ -0.0102 0.3299 0.3306 0.9465 -0.0070 0.3562 0.3497 0.9425
θ̂B -0.0023 0.2073 0.1980 0.9380 -0.0051 0.2200 0.2096 0.9295
θ̂A -0.0020 0.2137 0.1999 0.9340 -0.0352 0.7085 0.2280 0.9015
II X1 θ̂ -0.0076 0.4882 0.4903 0.9460 -0.0131 0.5116 0.5141 0.9430
θ̂B -0.0073 0.4993 0.4841 0.9380 -0.0143 0.5838 0.5617 0.9400
θ̂A -0.0072 0.4890 0.4895 0.9475 -0.0159 0.4929 0.4938 0.9440
X1, D2 θ̂ -0.0103 0.4869 0.4903 0.9485 -0.0113 0.5099 0.5029 0.9420
θ̂B -0.0121 0.4990 0.4776 0.9375 -0.0090 0.5470 0.5125 0.9270
θ̂A -0.0108 0.4908 0.4895 0.9450 -0.0435 0.8393 0.5090 0.9325
III X1 θ̂ 0.0057 0.3864 0.3869 0.9445 -0.0174 0.3722 0.3726 0.9475
θ̂B 0.0038 0.3348 0.3270 0.9380 -0.0071 0.3754 0.3658 0.9425
θ̂A 0.0040 0.3314 0.3291 0.9420 0.0006 0.3435 0.3396 0.9420
X1, D2 θ̂ -0.0104 0.3566 0.3569 0.9505 -0.0078 0.3625 0.3569 0.9445
θ̂B 0.0067 0.3369 0.3234 0.9310 0.0082 0.3652 0.3451 0.9310
θ̂A -0.0012 0.3369 0.3289 0.9400 -0.0388 1.0589 0.3615 0.9225
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